RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 104 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $566,000 | +528.9% | 220,164 | +461.4% | 0.12% | +875.0% |
| Q4 2018 | $90,000 | +69.8% | 39,220 | +163.9% | 0.01% | +200.0% |
| Q1 2018 | $53,000 | +55.9% | 14,861 | +38.8% | 0.00% | -66.7% |
| Q2 2015 | $34,000 | +3.0% | 10,706 | -37.9% | 0.01% | -36.8% |
| Q3 2014 | $33,000 | -89.4% | 17,239 | -84.2% | 0.02% | -84.7% |
| Q4 2013 | $312,000 | – | 109,452 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,020,719 | $3,746,000 | 2.58% |
| Boxer Capital, LLC | 1,351,137 | $4,959,000 | 2.22% |
| Palo Alto Investors LP | 5,186,088 | $19,033,000 | 1.11% |
| DAFNA Capital Management LLC | 340,000 | $1,248,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 907,203 | $3,329,435,000 | 0.86% |
| Rhenman & Partners Asset Management AB | 1,400,000 | $5,138,000,000 | 0.82% |
| NEA Management Company, LLC | 3,243,150 | $11,902,000 | 0.53% |
| Cormorant Asset Management, LP | 1,155,600 | $4,241,000 | 0.47% |
| Ghost Tree Capital, LLC | 700,000 | $2,569,000 | 0.42% |
| Rock Springs Capital Management LP | 1,810,000 | $6,643,000 | 0.42% |